Localized intermediate-risk or high-risk prostate cancer cT3
Gleason score = 7 (3+4 and/or 4+3) and/or
PSA = 20 ng/ml
intact preoperative erectile function with an IIEF = 21 (IIEF-6).

NCT01770340_inc_T1
Qualifier
high-risk
NCT01770340_inc_T2
Qualifier
cT3
NCT01770340_inc_T3
Qualifier
intermediate-risk
NCT01770340_inc_T4
Condition
prostate cancer
NCT01770340_inc_T5
Scope
intermediate-risk or high-risk
NCT01770340_inc_T6
Measurement
Gleason score
NCT01770340_inc_T7
Value
= 7
NCT01770340_inc_T8
Value
3+4
NCT01770340_inc_T9
Value
4+3
NCT01770340_inc_T10
Scope
3+4 and/or 4+3
NCT01770340_inc_T11
Measurement
PSA
NCT01770340_inc_T12
Value
= 20 ng/ml
NCT01770340_inc_T13
Condition
act pr ctile function wi
NCT01770340_inc_T14
Temporal
preoperative
NCT01770340_inc_T15
Measurement
IIEF
NCT01770340_inc_T16
Value
= 21
NCT01770340_inc_T17
Observation
IIEF-6
NCT01770340_inc_T18
Scope
IIEF = 21